Peritoneal Dialysis Registration System (PERSIST) for End Stage Renal Disease Patients

What this Trial Is About

Researchers are creating a database by registering all patients with end stage renal disease (ESRD) receiving peritoneal dialysis (PD) treatment at selected hospitals in China. This observational study aims to collect and analyze detailed demographic, clinical, and treatment data to better understand long-term outcomes for PD patients, including survival, complications, and quality of life. Patients' baseline information such as age, gender, height, weight, smoking and drinking habits, education, primary cause of ESRD, dialysis prescriptions, clinical lab results, drug use, and complications will be collected. Participants will be followed every three months to update clinical data, complications, drug information, and quality of life scores. The study will track outcomes like patient survival, technique survival, peritonitis rates, hospitalizations, kidney transplantation, and transfers to hemodialysis up to 10 years. During the study, patients will undergo regular follow-ups every three months where demographic and clinical data, lab results, and quality of life measurements will be gathered and entered into the registry system. The research team will analyze trends in patient survival, technical survival of PD, changes in kidney and peritoneal function, and complication rates over time. This long-term registry will provide valuable insights into PD patient outcomes and treatment effectiveness.

Peritoneal Dialysis Registration System (PERSIST)